Anixa Biosciences Inc
ANIX
Get informed when a big investor buys or sells
+ FollowMarket Cap$126.23M
Close$
$0.03
99.2% downside
Current Fair Value
99.2% downsideOvervalued by 99.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $126.23 Million |
|---|---|
| Enterprise Value | $124.93 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.34 |
| Beta | 0.6 |
| Outstanding Shares | 33,593,000 |
Return
| Return on Equity | -54.00% |
|---|---|
| Return on Assets | -52.58% |
| Return on Invested Capital | -79.06% |
Valuation & Multiples
| P/E Ratio | -12.44 |
|---|---|
| PEG | 148.29 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.83 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 10, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 9, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 53,400▼ 24.68% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.94%▲ 0.74% |
|---|---|
| Total Invested | $14.99M▲ 13.73% |
| Investors Holding | 65▲ 2.00% |
ESG Score
No data
About Anixa Biosciences Inc
CEO: Amit Kumar